# Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine)

> **NCT07214285** · PHASE1,PHASE2 · RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 1 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** A-DOPAMINE
- **DEVICE:** A-DOPAMINE

## Key facts

- **NCT ID:** NCT07214285
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2025-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07214285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07214285, "Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07214285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*